Cargando…
Histone Acetylation and Modifiers in Renal Fibrosis
Histones are the most abundant proteins bound to DNA in eukaryotic cells and frequently subjected to post-modifications such as acetylation, methylation, phosphorylation and ubiquitination. Many studies have shown that histone modifications, especially histone acetylation, play an important role in...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086452/ https://www.ncbi.nlm.nih.gov/pubmed/35559244 http://dx.doi.org/10.3389/fphar.2022.760308 |
_version_ | 1784704003974627328 |
---|---|
author | Shen, Fengchen Zhuang, Shougang |
author_facet | Shen, Fengchen Zhuang, Shougang |
author_sort | Shen, Fengchen |
collection | PubMed |
description | Histones are the most abundant proteins bound to DNA in eukaryotic cells and frequently subjected to post-modifications such as acetylation, methylation, phosphorylation and ubiquitination. Many studies have shown that histone modifications, especially histone acetylation, play an important role in the development and progression of renal fibrosis. Histone acetylation is regulated by three families of proteins, including histone acetyltransferases (HATs), histone deacetylases (HDACs) and bromodomain and extraterminal (BET) proteins. These acetylation modifiers are involved in a variety of pathophysiological processes leading to the development of renal fibrosis, including partial epithelial-mesenchymal transition, renal fibroblast activation, inflammatory response, and the expression of pro-fibrosis factors. In this review, we summarize the role and regulatory mechanisms of HATs, HDACs and BET proteins in renal fibrosis and provide evidence for targeting these modifiers to treat various chronic fibrotic kidney diseases in animal models. |
format | Online Article Text |
id | pubmed-9086452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90864522022-05-11 Histone Acetylation and Modifiers in Renal Fibrosis Shen, Fengchen Zhuang, Shougang Front Pharmacol Pharmacology Histones are the most abundant proteins bound to DNA in eukaryotic cells and frequently subjected to post-modifications such as acetylation, methylation, phosphorylation and ubiquitination. Many studies have shown that histone modifications, especially histone acetylation, play an important role in the development and progression of renal fibrosis. Histone acetylation is regulated by three families of proteins, including histone acetyltransferases (HATs), histone deacetylases (HDACs) and bromodomain and extraterminal (BET) proteins. These acetylation modifiers are involved in a variety of pathophysiological processes leading to the development of renal fibrosis, including partial epithelial-mesenchymal transition, renal fibroblast activation, inflammatory response, and the expression of pro-fibrosis factors. In this review, we summarize the role and regulatory mechanisms of HATs, HDACs and BET proteins in renal fibrosis and provide evidence for targeting these modifiers to treat various chronic fibrotic kidney diseases in animal models. Frontiers Media S.A. 2022-04-26 /pmc/articles/PMC9086452/ /pubmed/35559244 http://dx.doi.org/10.3389/fphar.2022.760308 Text en Copyright © 2022 Shen and Zhuang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Shen, Fengchen Zhuang, Shougang Histone Acetylation and Modifiers in Renal Fibrosis |
title | Histone Acetylation and Modifiers in Renal Fibrosis |
title_full | Histone Acetylation and Modifiers in Renal Fibrosis |
title_fullStr | Histone Acetylation and Modifiers in Renal Fibrosis |
title_full_unstemmed | Histone Acetylation and Modifiers in Renal Fibrosis |
title_short | Histone Acetylation and Modifiers in Renal Fibrosis |
title_sort | histone acetylation and modifiers in renal fibrosis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086452/ https://www.ncbi.nlm.nih.gov/pubmed/35559244 http://dx.doi.org/10.3389/fphar.2022.760308 |
work_keys_str_mv | AT shenfengchen histoneacetylationandmodifiersinrenalfibrosis AT zhuangshougang histoneacetylationandmodifiersinrenalfibrosis |